Key Drivers
- Profitability Strong
- Cash Conversion Weak
- Leverage Elevated
AIAI Summary
NMR is shifting from a cheap cyclical financial to a higher-quality franchise with better earnings mix and capital returns, but until its strong reported profits translate into positive free cash flow and the balance-sheet burden eases, it remains a credible hold rather than a high-conviction buy.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability Strong
- •Cash Conversion Weak
- •Leverage Elevated
NMR delivered strong reported profitability and a modest valuation, but weak cash conversion and high leverage materially weaken the investment case.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Support holding
- •Breakout needed
NMR's price action is constructive, with higher lows and support around $8.60–$8.80, but a break above $9.10 is needed to confirm stronger upside momentum.
Late-June pullback and choppy trading followed the $9.10 high
Sentiment & News
Key News Insights:
- •Revenue Momentum
- •Record Profit
- •Valuation Debate
Nomura's stronger wholesale revenue, record profit, and higher CEO pay highlight improving momentum, but the stock remains in a valuation debate over how much upside is already priced in.
The news is modestly positive for Nomura's fundamentals, but the shares may stay sensitive to whether earnings growth continues to justify the current valuation
Similar Companies in Financial Services
Other companies in the same sector with AI ratings